Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yang, Xiao Dong, Su, Qiaojuan Jane, Feng, Xiao, Rathanaswami, Palaniswami, Corvalan, Jose R. F, Weber, Richard F, Keyt, Bruce A, Raya, Robert, Gudas, Jean M, Foltz, Ian, Kang, Jaspal Singh, Klakamp, Scott L, Foord, Orit, Jia, Xiao-Chi, Liu, Ying, King, Chadwick Terence, Green, Larry L
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.